Two classic oncogene mutations in NSCLC are epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) chromosome rearrangement (the most common one is EML4-ALK fusion) (52). This evidence concerns the gene ALK and non-small cell lung carcinoma.